phenylalanine has been researched along with Peritoneal Carcinomatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlier, C; Ceelen, WP; De Vlieghere, E; Gullbo, J; Juntti, T; Larsson, R; Lewensohn, R; Nygren, P; Spira, J; Strese, S; Uustalu, M; Velander, E; Viktorsson, K | 1 |
| Aparicio, T; Dessirier, V; Kermorgant, S; Lehy, T; Lewin, MJ | 1 |
2 other study(ies) available for phenylalanine and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Preclinical activity of melflufen (J1) in ovarian cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cytoreduction Surgical Procedures; Disease-Free Survival; Drug Evaluation, Preclinical; Female; Humans; Hyperthermia, Induced; Injections, Intraperitoneal; Melphalan; Mice; Mice, SCID; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Phenylalanine; Xenograft Model Antitumor Assays | 2016 |
Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats.
Topics: Animals; Antineoplastic Agents; Carcinoma; Collagenases; Colonic Neoplasms; Female; Gelatinases; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Neoplasm Invasiveness; Neoplasm Proteins; Peritoneal Neoplasms; Phenylalanine; Rats; Thiophenes; Tumor Cells, Cultured | 1999 |